Ann: Increased Scheme Consideration from Pfizer, page-223

Both are too low offers. If tests are satisfying why the hell sell company for a bargain. If not satisfying they want the company too. This tells me they absolutely want to have this beauty. "No"-vote till they offer billions. Everything else makes no sense. I really start to think that RAP is the biggest deal at asx in 2022 or even LT. I can wait. tech works (we have approvals) and now very likely also with Covid. Stay strong vote no. Sentiment "Buy" but can change fast into sell again . ;-) IMO